Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study
PLOS Medicine · 04.06.2026 · 23 (6) · e1004739
DOI: 10.1371/journal.pmed.1004739 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS Medicine, online erschienen am 04.06.2026. Verfasst von Yiran E Liu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, United States of America. Hauptthemen laut MEDLINE: Mass Screening, Prisons, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico.
Abstract (Originalsprache)
Background
Incarceration is a leading driver of tuberculosis in Latin America. Systematic screening in prisons may reduce tuberculosis burden, but optimal strategies and cost-effectiveness remain uncertain. We examined the population-wide health impacts and cost-effectiveness of systematic screening in prisons in Brazil, Colombia, and Peru, comparing different timepoints, frequencies, and screening algorithms. Methods and findings Using dynamic transmission models calibrated to Brazil, Colombia, and Peru, we simulated annual or biannual (twice-yearly) prison-wide screening, alone or combined with entry and exit screening from 2026 to 2035. We evaluated four algorithms: (1) symptom screening, (2) chest X-ray with computer-aided detection (CXR-CAD), (3) symptoms and CXR-CAD (follow-up testing if either is positive), and (4) GeneXpert Ultra (Xpert) with pooled sputum. Individuals screening positive then received individual Xpert. We projected impacts on within-prison and population-level tuberculosis incidence in 2035, along with discounted costs (2023 US dollars) and disability-adjusted life years (DALYs). Model projections showed that combined entry, exit, and biannual screening with CXR-CAD was highly impactful and cost-effective across countries, reducing tuberculosis incidence by 61%–87% in prisons and 18%–28% population-wide. Compared to only biannual CXR-CAD (the next best strategy), the incremental cost per DALY averted of adding entry and exit screening was $2,984 (Brazil), $2,925 (Colombia), and $645 (Peru). Adding symptom screening to CXR-CAD marginally increased benefit and was only cost-effective in Peru’s higher-incidence prisons. Biannual screening alone remained cost-effective at prison incidence levels well below national averages, as well as at far lower willingness-to-pay thresholds. In settings without CXR-CAD, pooled Xpert was an impactful, cost-effective alternative. Key limitations include the model’s simplified representation of tuberculosis disease states and lack of stratification by age, gender/sex, HIV, or drug resistance.
Conclusions
These modeling results support immediate national-level adoption of prison-wide tuberculosis screening twice-yearly and at entry and exit, using CXR-CAD or pooled Xpert.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, United States of America.
- SEICHE Center for Health and Justice, Yale University School of Medicine, New Haven, Connecticut, United States of America.
- Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
- National Tuberculosis Program, Ministry of Health, Brasília, Brazil.
- Pan American Health Organization, Communicable Diseases Prevention, Control and Elimination, Washington, District of Columbia, United States of America.
- Dirección de Prevención y Control de la Tuberculosis, Ministerio de Salud, Lima, Peru.
ORCID-Profile: Yiran E Liu, José Victor Bortolotto Bampi, Ronan F Arthur, Argita D Salindri, Robert Arana-Narvaez, Wilfredo Santos Solís Tupes, Esther Mori Jiu, Christian Alfredo Moreno Roca, Valentina Antonieta Alarcón Guizado, Ted Cohen, Moises A Huaman, Jeremy D Goldhaber-Fiebert, Julio Croda, Jason R Andrews
Förderung
- National Institutes of Health
- Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico
Zitieren
APA
Liu, Y. E., Bampi, J. V. B., Arthur, R. F., Salindri, A. D., Busatto, C., Jiménez, P. A., Pelissari, D. M., Johansen, F. D. C., Arana-Narvaez, R., Roca, A. F. M., Solís Tupes, W. S., Jiu, E. M., Roca, C. A. M., Abregú Contreras, E. A., Guizado, V. A. A., Trujillo, J. T., Marcelino, B., Gonzalez, M. A., Córdova Ayllon, M. C., …, & Andrews, J. R. (2026). Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study. PLOS Medicine, 23(6), e1004739. https://doi.org/10.1371/journal.pmed.1004739
Vancouver
Liu YE, Bampi JVB, Arthur RF, Salindri AD, Busatto C, Jiménez PA, et al. Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study. PLOS Medicine. 2026;23(6):e1004739. doi:10.1371/journal.pmed.1004739
BibTeX
@article{Liu2026,
author = {Liu, Yiran E and Bampi, José Victor Bortolotto and Arthur, Ronan F and Salindri, Argita D and Busatto, Caroline and Jiménez, Pedro Avedillo and Pelissari, Daniele Maria and Johansen, Fernanda Dockhorn Costa and Arana-Narvaez, Robert and Roca, Alvaro Fernando Moreno and Solís Tupes, Wilfredo Santos and Jiu, Esther Mori and Roca, Christian Alfredo Moreno and Abregú Contreras, Erika Albertina and Guizado, Valentina Antonieta Alarcón and Trujillo, Julián Trujillo and Marcelino, Belkys and Gonzalez, Mónica Alonso and Córdova Ayllon, Mayra Cecilia and Cohen, Ted and Huaman, Moises A and Goldhaber-Fiebert, Jeremy D and Croda, Julio and Andrews, Jason R},
title = {Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {6},
pages = {e1004739},
doi = {10.1371/journal.pmed.1004739}
}
EUVIMED